Optiray Injection
NDC Package 0019-1333-91

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Optiray (ioversol) injection is optiray is indicated for:. This formulation utilizes a injection delivery system. Marketed by Liebel-flarsheim Company Llc, this product is identified by NDC 0019-1333 and is authorized under FDA application NDA019710.

Identification & Billing

NDC Package Code
0019-1333-91
Package Description
20 SYRINGE, PLASTIC in 1 CARTON / 75 mL in 1 SYRINGE, PLASTIC
Product Code
11-Digit Billing Format
00019133391
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Optiray 350
Non-Proprietary Name
Ioversol
Substance Name
Ioversol
Dosage Form
Injection - A sterile preparation intended for parenteral use; five distinct classes of injections exist as defined by the USP.
Administration Route
  • Intra-arterial - Administration within an artery or arteries.
  • Intravenous - Administration within or into a vein or veins.
  • Intra-arterial - Administration within an artery or arteries.
  • Intravenous - Administration within or into a vein or veins.
  • Intra-arterial - Administration within an artery or arteries.
  • Intravenous - Administration within or into a vein or veins.
Usage Information
Optiray is indicated for:

Regulatory & Marketing

Labeler Name
Liebel-flarsheim Company Llc
Product Type
Human Prescription Drug
FDA Application #
NDA019710
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
03-04-2012
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0019-1333). Click a package code to view its specific billing and regulatory data.

20 SYRINGE, PLASTIC in 1 CARTON / 100 mL in 1 SYRINGE, PLASTIC
25 BOTTLE, GLASS in 1 CARTON / 50 mL in 1 BOTTLE, GLASS
12 BOTTLE, GLASS in 1 CARTON / 100 mL in 1 BOTTLE, GLASS
12 BOTTLE, GLASS in 1 CARTON / 150 mL in 1 BOTTLE, GLASS
12 BOTTLE, GLASS in 1 CARTON / 200 mL in 1 BOTTLE, GLASS
20 SYRINGE, PLASTIC in 1 CARTON / 125 mL in 1 SYRINGE, PLASTIC
12 BOTTLE, GLASS in 1 CARTON / 250 mL in 1 BOTTLE, GLASS
20 SYRINGE, PLASTIC in 1 CARTON / 50 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 50 mL in 1 SYRINGE, PLASTIC
6 BOTTLE, GLASS in 1 CARTON / 500 mL in 1 BOTTLE, GLASS
6 BOTTLE, GLASS in 1 CARTON / 500 mL in 1 BOTTLE, GLASS
20 SYRINGE, PLASTIC in 1 CARTON / 50 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 50 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 50 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 125 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 100 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 75 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 125 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 100 mL in 1 SYRINGE, PLASTIC
20 SYRINGE, PLASTIC in 1 CARTON / 75 mL in 1 SYRINGE, PLASTIC

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0019-1333-91 identifies a specific commercial package of 20 syringe, plastic in 1 carton / 75 ml in 1 syringe, plastic of Optiray 350, a human prescription drug labeled by Liebel-flarsheim Company Llc. This injection is formulated for intra-arterial; intravenous use and contains ioversol as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Liebel-flarsheim Company Llc on March 04, 2012. The current certification is valid through December 31, 2026.

How is this Liebel-flarsheim Company Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00019133391. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0019-1333-91
11-Digit CMS (5-4-2)
00019-1333-91

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.